Page 1

labcorp FOR IMMEDIATE RELEASE Contact : Chas Cook ( investors ) - 336-436-5076 Investor@Labcorp.com - Christopher Allman - Bradshaw ( media ) – 336-436-8263 Media@Labcorp.com Labcorp Announces 2021 First Quarter Results Company Raises Full Year Guidance Revenue : Q1 of $ 4.2 billion , up from $ 2.8 billion last year • Diluted EPS : Q1 of $ 7.82 , up from ( $ 3.27 ) last year • • Adjusted EPS : Q1 of $ 8.79 , up from $ 2.37 last year Free Cash Flow : Q1 of $ 1.1 billion , up from $ 97 million last year Opened automated clinical trial kit production facility in Belgium Full Year 2021 Guidance : Revenue raised to 2.0 % to 6.5 % ; Adjusted EPS raised to $ 20.00 to $ 24.00 ; Free Cash Flow raised to $ 1.8 billion to $ 2.0 billion BURLINGTON , N.C. , April 29 , 2021 – Labcorp ( NYSE : LH ) , a leading life sciences company , today announced results for the first quarter ended March 31 , 2021 and raised 2021 guidance . " We delivered very strong results in the first quarter driven by revenue growth across both our Diagnostics and Drug Development businesses , " said Adam H. Schechter , chairman and CEO , Labcorp . " Overall revenue in our base business grew 14.6 % as people continued to return to their pre - pandemic healthcare routines and our biopharmaceutical clients resumed their important research and development . Our drug development pipeline remained robust , with a book - to - bill of 1.47 on a trailing twelve - month basis driven by strong demand across major therapeutic areas . " - more -